These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 3235480

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A graphical nomogram method for predicting toxic concentrations of unbound phenytoin.
    Pospisil J, Pelclová D.
    Int J Clin Pharmacol Ther; 1994 Mar; 32(3):122-5. PubMed ID: 8205372
    [Abstract] [Full Text] [Related]

  • 24. A comparison of graphical nomogram methods with a computerized Bayesian analysis method in the interpretation of serum phenytoin concentrations.
    Chrystyn H, Morgan DH.
    J Clin Hosp Pharm; 1986 Dec; 11(6):443-8. PubMed ID: 3818966
    [Abstract] [Full Text] [Related]

  • 25. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
    Fukuoka N, Uno J, Tsukamoto T, Houchi H, Kimura M, Morita S.
    Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
    [Abstract] [Full Text] [Related]

  • 26. Clinical utility of a Bayesian dosing program for phenytoin.
    Privitera MD, Homan RW, Ludden TM, Peck CC, Vasko MR.
    Ther Drug Monit; 1989 Feb; 11(3):285-94. PubMed ID: 2728087
    [Abstract] [Full Text] [Related]

  • 27. Rapid i.v. loading with phenytoin with subsequent dose adaptation using non-steady-state serum levels and a Bayesian forecasting computer program to predict maintenance doses.
    Martinelli EF, Mühlebach SF.
    J Clin Pharm Ther; 2003 Oct; 28(5):385-93. PubMed ID: 14632963
    [Abstract] [Full Text] [Related]

  • 28. Comparison of a Bayesian forecasting technique with a new method for estimating phenytoin dose requirements.
    Bryson SM, Al-Lanqawi Y, Kelman AW, Whiting B.
    Ther Drug Monit; 1988 Oct; 10(1):80-4. PubMed ID: 3376186
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.
    Garrelts JC, Godley PJ, Horton MW, Karboski JA.
    Clin Pharm; 1987 Oct; 6(10):795-9. PubMed ID: 3505841
    [Abstract] [Full Text] [Related]

  • 31. Bayesian regression analysis of non-steady-state phenytoin concentrations: evaluation of predictive performance.
    Killilea T, Coleman R, Ludden T, Peck CC, Rose D.
    Ther Drug Monit; 1989 Oct; 11(4):455-62. PubMed ID: 2741195
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of a proposed method for phenytoin maintenance dose prediction following an intravenous loading dose.
    Crowley JJ, Koup JR, Cusack BJ, Ludden TM, Vestal RE.
    Eur J Clin Pharmacol; 1987 Oct; 32(2):141-8. PubMed ID: 3582477
    [Abstract] [Full Text] [Related]

  • 33. Use of plasma unbound drug concentrations in adjusting phenytoin doses.
    Bachmann K, Voeller K, Forney R.
    Ther Drug Monit; 1984 Oct; 6(2):173-8. PubMed ID: 6740736
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of Binding Equation Method for Unbound Serum Concentration Prediction of Valproic Acid in Polytherapy Pediatric Patients with Epilepsy.
    Kodama Y, Kuranari M, Kodama H, Ashikari Y, Fujii I, Takeyama M.
    Am J Ther; 1995 Feb; 2(2):106-111. PubMed ID: 11847536
    [Abstract] [Full Text] [Related]

  • 35. Carbamazepine-phenytoin interaction: elevation of plasma phenytoin concentrations due to carbamazepine comedication.
    Zielinski JJ, Haidukewych D, Leheta BJ.
    Ther Drug Monit; 1985 Feb; 7(1):51-3. PubMed ID: 3992622
    [Abstract] [Full Text] [Related]

  • 36. Bioavailability of phenytoin acid and phenytoin sodium with enteral feedings.
    Doak KK, Haas CE, Dunnigan KJ, Reiss RA, Reiser JR, Huntress J, Altavela JL.
    Pharmacotherapy; 1998 Feb; 18(3):637-45. PubMed ID: 9620116
    [Abstract] [Full Text] [Related]

  • 37. Comparative analysis of the pharmacokinetic techniques available for individualizing phenytoin dosage.
    Messori A, Zaccara G, Valenza T, Arnetoli G, Bartoli C, Donati-Cori G, Muscas GC, Tendi E.
    J Clin Hosp Pharm; 1983 Dec; 8(4):357-65. PubMed ID: 6689330
    [Abstract] [Full Text] [Related]

  • 38. Phenytoin clearances in a compliant population: description and application.
    Graves NM, Leppik IE, Termond E, Taylor JW.
    Ther Drug Monit; 1986 Dec; 8(4):427-33. PubMed ID: 3824428
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
    Niioka T, Uno T, Yasui-Furukori N, Takahata T, Shimizu M, Sugawara K, Tateishi T.
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):575-80. PubMed ID: 16912889
    [Abstract] [Full Text] [Related]

  • 40. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
    Ramsay E, Faught E, Krumholz A, Naritoku D, Privitera M, Schwarzman L, Mao L, Wiegand F, Hulihan J, CAPSS-272 Study Group.
    Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.